Variantyx Inc. raised $20 million in a series C financing led by GHS Fund (Quark Venture LP and GF Securities). The new funds are earmarked for the development of comprehensive tumor diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback